
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Author(s) -
Zhao Chen,
Kuan Chen Cheng,
Zandra E. Walton,
Yuchuan Wang,
Hiromichi Ebi,
Takeshi Shimamura,
Yan Liu,
Tanya Tupper,
Jun Ouyang,
Jie Li,
Peng Gao,
Michele S. Woo,
Chunxiao Xu,
Masahiko Yanagita,
Abigail Altabef,
Shumei Wang,
Charles Lee,
Yuji Nakada,
Christopher G. Peña,
Yi Sun,
Yoko Franchetti,
Chia-Yu Yao,
Amy Saur,
Michael D. Cameron,
Mizuki Nishino,
D. Neil Hayes,
Matthew D. Wilkerson,
Patrick Roberts,
Carrie B. Lee,
Nabeel Bardeesy,
Mohit Butaney,
Lucian R. Chirieac,
Daniel Benevides da Costa,
David M. Jackman,
Norman E. Sharpless,
Diego H. Castrillón,
George D. Demetri,
Pasi A. Jänne,
Pier Paolo Pandolfi,
Lewis C. Cantley,
Andrew L. Kung,
Jeffrey A. Engelman,
Kwok-Kin Wong
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d9z4-0943
Subject(s) - lung cancer , clinical trial , medicine , cancer , oncology , complete response , biology , chemotherapy